These products are labeled "for research use only" and are not intended for human use
Published research characterises AOD-9604 as retaining the lipolytic domain of hGH while lacking measurable activity at the GH receptor animal-model studies have therefore reported lipolytic effects without the IGF-1, insulin-resistance or growth-promoting changes associated with intact growth hormone
During energy deficit, fasting, or physical activity, SIRT1 activity is upregulated, supporting glucose utilization and inhibiting gluconeogenesis
GLP-1 RAs, by improving metabolic parameters, reduce the risk of obesity-related comorbidities like type 2 diabetes and cardiovascular issues
Complementary Lifestyle Factors: Sleep quality, stress management, and regular physical activity all influence GLP-1 production and sensitivity